RT Journal Article
SR Electronic
T1 No magic bullet: limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.25.22272956
DO 10.1101/2022.03.25.22272956
A1 Van Egeren, Debra
A1 Stoddard, Madison
A1 Malakar, Abir
A1 Ghosh, Debayan
A1 Acharya, Antu
A1 Mainuddin, Sk
A1 Majumdar, Biswajit
A1 Luo, Deborah
A1 Nolan, Ryan
A1 Joseph-McCarthy, Diane
A1 White, Laura F.
A1 Hochberg, Natasha S.
A1 Basu, Saikat
A1 Chakravarty, Arijit
YR 2022
UL http://medrxiv.org/content/early/2022/03/31/2022.03.25.22272956.abstract
AB In the face of a long-running pandemic, understanding the drivers of ongoing SARS-CoV-2 transmission is crucial for the rational management of COVID-19 disease burden. Keeping schools open has emerged as a vital societal imperative during the pandemic, but in-school transmission of SARS-CoV-2 can contribute to further prolonging the pandemic. In this context, the role of schools in driving SARS-CoV-2 transmission acquires critical importance. Here we model in-school transmission from first principles to investigate the effectiveness of layered mitigation strategies on limiting in-school spread. We examine the effect of masks and air quality (ventilation, filtration and ionizers) on steady-state viral load in classrooms, as well as on the number of particles inhaled by an uninfected person. The effectiveness of these measures in limiting viral transmission is assessed for variants with different levels of mean viral load (Wuhan, Delta, Omicron). Our results suggest that a layered mitigation strategy can be used effectively to limit in-school transmission, with certain limitations. First, poorly designed strategies (insufficient ventilation, no masks, staying open under high levels of community transmission) will permit in-school spread even if some level of mitigation is ostensibly present. Second, for viral variants that are sufficiently contagious, it may be difficult to construct any set of interventions capable of blocking transmission once an infected individual is present, underscoring the importance of other measures. Our findings provide several practical recommendations: the use of a layered mitigation strategy that is designed to limit transmission, with other measures such as frequent surveillance testing and smaller class sizes (such as by offering remote schooling options to those who prefer it) as needed.Competing Interest StatementA.C. and M.S. are employees of Fractal Therapeutics. R.N. is an employee of Halozyme Therapeutics. A.C., M.S., R.N., D.V.E., and D.J.-M. are shareholders in Fractal Therapeutics.Funding StatementThis material is based upon work partially supported by the National Science Foundation (NSF) RAPID Grant 2028069 for COVID-19 research, with SB as the Principal Investigator. Any opinions, findings, and conclusions or recommendations expressed here are, however, those of the author and do not necessarily reflect NSF's views. Fractal Therapeutics provided salary support for author M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAirborne viral concentration simulation data are reproducible using the code available at https://github.com/dvanegeren/covid-indoor-transmission. All additional data are available from the authors upon reasonable request. https://github.com/dvanegeren/covid-indoor-transmission